Host Julia Cartwright explores how Novo Nordisk transformed GLP-1, a hormone the body destroys in two minutes, into semaglutide—a once-weekly medication lasting seven days. Learn the molecular engineering behind Ozempic, Wegovy, and Rybelsus, including amino acid modifications, albumin binding, and absorption enhancers that turned a fragile gut hormone into a groundbreaking diabetes and obesity treatment.
Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV
This content was created in partnership and with the help of Artificial Intelligence AI
続きを読む
一部表示